Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of June 2024. The filing, dated June 12, 2024, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a standalone financial statement.
Material Changes
The filing text does not provide data to compare against prior periods. No material changes in financial position are detailed within the cover page text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are contained within the attached press release (Exhibit 99.1), which is incorporated by reference. The cover page text itself does not disclose these details.
Key Facts for Investor Verification
- Verify the content of the press release dated June 12, 2024, attached as Exhibit 99.1, as it contains the substantive information for this filing.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.